Finding new medicines to fight CF and ultimately cure this disease is the driving force behind the Cystic Fibrosis Foundation. To achieve this goal, we aggressively invest in drug development research with the most successful and innovative biotech companies and scientists in the world. In keeping with this business model, Cystic Fibrosis Foundation Therapeutics, Inc., the Foundation's nonprofit drug development affiliate, customarily enters into contractual agreements with pharmaceutical companies to receive royalties after the approval and/or sale of certain drugs that are developed as a result of CFFT funding. Any royalties CFFT receives are reinvested in support of our mission.
We're attacking the disease from every angle. Click on the interactive pipeline below to learn more about CF drugs in development or already in use by patients. The Foundation is propelling each of these medicines forward and will not stop until there is a cure.